A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Clinical trial NCT06055959 · RECRUITING

Trial details

NCT number: NCT06055959
Sponsor: UCB Biopharma SRL
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis

Start date: 2024-10-16
Primary completion: 2026-11-16
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.